Sequenom, Inc. (SQNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sequenom, Inc. (SQNM)

SQNM 2.390

0.0%

Sep 8 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (95)	4/4/2002 9:07:18 AM
From: nigel bates	Read Replies (1) of 364

SEQUENOM Sells 11 MassARRAY(TM) Systems During First Quarter of 2002 SAN DIEGO, April 4 /PRNewswire-FirstCall/ -- SEQUENOM(TM), Inc. (Nasdaq: SQNM - news), a discovery genetics company, today announced the sale of 11 additional MassARRAY systems, the Company's leading technology platform for high-throughput analysis of genetic variations. This increases the installed base of systems at customer sites to 66 worldwide. The new sales for the quarter include a number of new high profile accounts as well as repeat customers.* ``We are pleased to see the consistent demand for our MassARRAY technology continue,'' said Toni Schuh, Ph.D., SEQUENOM's President and Chief Executive Officer. ``We are also pleased to report that our ultra-high throughput genotyping facility is now up and running. This facility is enabling us to complete the large-scale studies necessary to determine the medical impact of genes and genetic variations for our SEQUENOM Pharmaceuticals business unit and for our customers.''...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next